OpenAlex
PricingAboutJobs
Log inGet started
Work

Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression

HTML

Year: 2001
Type: article
Source: Archives of Neurology
DOI: 10.1001/archneur.58.3.417
Authors: Martin R. Farlow, Ann Hake, John Messina, Richard Hartman, Jeffrey Veach, Ravi Anand
Institutions: Indiana University Indianapolis, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, rivastigmine, cholinesterase inhibitors, disease progression rate, treatment response prediction, open-label extension, cognitive decline, ADAS-Cog, disease severity
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Aging
Awards: Indiana Alzheimer Disease Center, G1713611156
OpenAlex ID: W1978342865
FWCI: 5.487
Cites: 23
Cited by: 106
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security